AstraZeneca AZN has announced positive results from the phase III CAPItello-281 study, which evaluated a combination regimen ...

LT4 monotherapy remains the standard treatment for hypothyroidism, although a subset of patients continues to have ...

The CAPItello-281 trial aimed to assess the safety and efficacy of Truqap in combination with abiraterone and ADT.

[5] This was the rationale for the Medical Therapy of Prostatic Symptoms (MTOPS) study. Rather than concentrate on the effect of combination therapy on longitudinal changes, the aim of this trial ...

Smoking cessation in severe tobacco dependence: benefit proven for two of four drugs Varenicline and nicotine offer clear advantages for smokers who are severely addicted to tobacco. There is a lack ...

Truqap combination showed a statistically and clinically meaningful improvement in radiographic progression-free survival for ...

Dana-Farber Cancer Institute authors: Giuseppe Tarantino, PhD, David Liu, MD, MPH ...

A new combination therapy is showing promise in reducing facial redness caused by rosacea, a common skin condition.

The observed changes were favorable, but results may have been affected by better-than-normal care in the control arm.

The discovery of antibiotics is one of the greatest medical breakthroughs of the 20th century. Before antibiotics, childbirth ...